|Articles|September 13, 2022
WCG IRB Expands Phase I Review Services, Partners With Dr. Vince Clinical Research
Expanded services will provide faster timelines in the clinical trial process for early stage and clinical pharmacology research.
Advertisement
WCG announced the expansion of its Phase I review services. Launched in conjunction with the opening of Dr. Vince Clinical Research’s (DVCR) research complex in Overland Park, Kansas—these services are intended to improve timelines in the clinical trial process while maintaining necessary human subject protection for early stage and clinical pharmacology research.
Read more about the expansion and partnership here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV PatientsSeptember 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG ResearchSeptember 12th 2025
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug TrialsSeptember 11th 2025
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
